May 2019
Financial Advisor for Fibrocell Science, Inc. on its collaboration agreement with Castle Creek Pharmaceuticals
Financial Advisor to Neuronetics on its Announced Merger with Greenbrook TMS
Advisor to UCB on the Sale of the Rights of Nootropil® and Atarax® Products to Advanz Pharma
Exclusive Financial Advisor (Buy side)
